Table 1. Average number of arrhythmias per animal for each group in each of the phases. “n” refers to the number of animals in each group.
CONTROL (n = 10) | LIDOCAINE (n = 11) | RILUZOLE (n = 6) | |||||
mean | SEM | mean | SEM | mean | SEM | ||
PVCs | Phase 1a0–20 mins | 38.90 | 15.57 | 53.00 | 28.68 | 49.33 | 21.11 |
Phase 1b20–50 mins | 134.10 | 39.08 | 102.45 | 50.96 | 148.67 | 31.84 | |
Phase 250–180 mins | 484.60 | 199.86 | 390.09 | 234.09 | 32.50 | 13.32 | |
TOTAL | 657.60 | 190.19 | 545.55 | 278.73 | 230.50 | 78.96 | |
Non-sustained arrhythmias | Phase 1a0–20 mins | 0.40 | 0.31 | 1.09 | 0.54 | 0.17 | 0.13 |
Phase 1b20–50 mins | 3.20 | 1.74 | 4.82 | 3.55 | 2.33 | 1.24 | |
Phase 250–180 mins | 8.90 | 4.41 | 0.45 | 0.33 | 0.67 | 0.52 | |
TOTAL | 12.50 | 4.15 | 6.36 | 3.77 | 3.17 | 2.26 | |
Sustained arrhythmias | Phase 1a0–20 mins | 0.40 | 0.27 | 0.27 | 0.20 | 0.17 | 0.13 |
Phase 1b20–50 mins | 1.80 | 0.44 | 0.55 | 0.26 | 0.17 | 0.13 | |
Phase 250–180 mins | 3.90 | 2.21 | 0.36 | 0.29 | 0.50 | 0.39 | |
TOTAL | 6.10 | 2.61 | 1.18 | 0.40 | 0.83 | 0.48 |